阿帕胺:中性致死性败血症的原因之一
Urwah Ali1, Omar Khan1, Venga Vengadasalam2
1Oncology, The Great Western Hospitals National Health Services (NHS) Foundation Trust, Swindon, GBR.
新的前列腺癌药物如阿帕胺通常是安全的,但罕见的中性贫血性败血症和骨髓抑制病例可能发生. 这一案例凸显了在治疗期间监测患者感染症状的重要性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 前列腺癌是癌症诊断和死亡率的主要原因.
- 以雄激素为向的疗法是各种前列腺癌阶段的标准治疗方法.
- 这些疗法通常耐受良好,副作用比传统化疗少.
研究的目的:
- 报告一个罕见的中性贫血性败血症和骨髓抑制病例.
- 为了突出与阿帕胺相关的潜在严重不良事件.
- 强调接受新型癌症疗法患者的警监测的重要性.
主要方法:
- 一个65岁的男性患者的病例报告.
- 患者被诊断为转移性激素敏感前列腺癌.
- 治疗涉及使用雄激素受体抑制剂阿帕胺.
主要成果:
- 患者出现了中性贫血性败血症和骨髓抑制.
- 这些不良事件发生,尽管阿帕胺的一般耐受性概况.
- 这代表了这种副作用的第二个已记录的病例,也是第一个涉及骨髓抑制的病例.
结论:
- 中性贫血性败血症和骨髓抑制是阿帕胺的罕见但严重的并发症.
- 警地监测血细胞计数和早期识别感染至关重要.
- 医疗保健提供者必须意识到这些潜在的风险,以便明智地管理患者.
更多相关视频
08:59Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment
Published on: August 3, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
相关概念视频
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Clinical Significance of Antibiotic Resistance
